2002
DOI: 10.1016/s0168-3659(01)00550-8
|View full text |Cite
|
Sign up to set email alerts
|

Formulation aspects in the development of osmotically controlled oral drug delivery systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
121
0
13

Year Published

2006
2006
2021
2021

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 247 publications
(134 citation statements)
references
References 37 publications
0
121
0
13
Order By: Relevance
“…As new innovation in oral controlled plasma drug delivery it avoids fluctuation in drug concentration and offers better drug utilization and patient compliance.So in the present study attempt has been made to control the release of Tramadol hydrochloride by two different approaches i.e. one using osmotic agents and other by changing the orifice size [2][3][4][5][6][7][8][9][10] . A semi permeable micro porous membrane that regulates the drug release surrounds the system.…”
Section: World Journal Of Pharmacy and Pharmaceutical Sciencesmentioning
confidence: 99%
“…As new innovation in oral controlled plasma drug delivery it avoids fluctuation in drug concentration and offers better drug utilization and patient compliance.So in the present study attempt has been made to control the release of Tramadol hydrochloride by two different approaches i.e. one using osmotic agents and other by changing the orifice size [2][3][4][5][6][7][8][9][10] . A semi permeable micro porous membrane that regulates the drug release surrounds the system.…”
Section: World Journal Of Pharmacy and Pharmaceutical Sciencesmentioning
confidence: 99%
“…Because mechanical deformation of gels is a simple matter, pressure-induced control of drug release from gel materials is also possible. Osmotic pressure has widely been used for controlling drug release from gel matrices, and many commercial products are already available [13]. However, drug release based on simple volume changes (i.e., swelling and shrinkage) may not provide highly specific drug release.…”
Section: Pressure-induced Drug Release From Gelmentioning
confidence: 99%
“…A liberação de fármacos a partir deste sistemas é independente de fatores fisiológicos do trato gastrointestinal. Ao modificar alguns fatores de formulação, como a solubilidade e pressão osmótica dos componentes do núcleo, o tamanho do orifício e a natureza da membrana que controla a entrada de água no sistema podem obter-se diferentes tempos de latência (Verma et al, 2002). O OROS-CT ® foi concebido para provocar um atraso pós-gástrico de 3 a 4 horas, evitando que a liberação ocorra no intestino delgado (Tweeuwes et al, 1993 …”
Section: Sistemas Tempo-dependentesunclassified